REGENERON PHARMACEUTICALS, INC. Business Segments Regeneron Pharmaceuticals, Inc.
Equities
REGN
US75886F1075
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,146.75 USD | -0.55% |
|
+0.92% | +30.57% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Biotechnology | 7.86B | 8.31B | 16.07B | 12.17B | 13.12B | |||||
Total Assets | 14.81B | 17.16B | 25.43B | 29.21B | 33.08B | |||||
Interest Expense | -30.2M | -56.9M | -57.3M | -59.4M | -73M | |||||
Income Tax Expense | 313M | 297M | 1.25B | 520M | 246M | |||||
CAPEX | -430M | -615M | -552M | -1.62B | -719M | |||||
EBT | 2.43B | 3.81B | 9.33B | 4.86B | 4.2B | |||||
D&A | 210M | 236M | 286M | 341M | 421M | |||||
Operating Income | 2.21B | 3.58B | 8.95B | 4.74B | 4.05B | |||||
Net Income | 2.12B | 3.51B | 8.08B | 4.34B | 3.95B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Rest of World (ROW) | 2.92B | 3.04B | - | - | - | |||||
United States | 4.83B | 5.22B | - | - | - | |||||
Total Assets | 2.12B | 2.4B | 2.68B | 2.96B | 3.38B | |||||
Total Assets | 773M | 824M | 798M | 803M | 771M |
- Stock Market
- Equities
- REGN Stock
- Financials Regeneron Pharmaceuticals, Inc.
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition